Back
Corcept Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
CORT
Corcept Therapeutics, Inc.
Last Price:
$39.97
Seasonality Move:
8.39%
7 Day Trial
ALL ACCESS PASS
$
7
Corcept Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 33.1% based on the past 21 years of stock performance.
-
Corcept Therapeutics, Inc. has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Corcept Therapeutics, Inc. Stock Undervalued?The current Corcept Therapeutics, Inc. [CORT] share price is $39.97. The Score for CORT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 33.1% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. Stock Rating
Sell
40
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. overpriced?
-
Corcept Therapeutics, Inc. has risen higher in 14 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Corcept Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
117.33
52-Week Low:
32.99
Prediction Charts
Market Cap:
4.2B
Price in USD:
39.97
Volume:
684.5K
Beta:
0.78
Technical Analysis
SMA50:
56.80
SMA100:
67.52
SMA200:
69.69
52-Wk Change:
-45.7%
Stock Predictions
-
Is Corcept Therapeutics, Inc. stock public?Yes, Corcept Therapeutics, Inc. is a publicly traded company.
-
What is the Corcept Therapeutics, Inc. stock quote today?The Corcept Therapeutics, Inc. stock price is 39.97 USD today.
-
How to buy Corcept Therapeutics, Inc. stock online?You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 45.53 | 46.22 | 46.29 | 43.52 |
| Jan-28 | 46.26 | 45.85 | 47.06 | 45.24 |
| Jan-29 | 45.74 | 44.61 | 46.09 | 44.34 |
| Jan-30 | 37.39 | 39.87 | 40.72 | 36.80 |
| Feb-2 | 39.87 | 40.71 | 42.26 | 39.63 |
| Feb-3 | 40.54 | 40.70 | 41.28 | 39.74 |
| Feb-4 | 41.02 | 40.13 | 41.36 | 39.42 |
| Feb-5 | 39.90 | 38.36 | 40.75 | 38.10 |
| Feb-6 | 39.01 | 40.83 | 40.85 | 38.68 |
| Feb-9 | 40.77 | 41.31 | 41.41 | 40.30 |
| Feb-10 | 41.28 | 40.97 | 41.92 | 40.82 |
| Feb-11 | 40.59 | 40.83 | 41.00 | 39.66 |
| Feb-12 | 40.85 | 38.34 | 40.85 | 38.00 |
| Feb-13 | 39.11 | 39.97 | 40.43 | 39.09 |
Corcept Therapeutics, Inc. Earnings
Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics, Inc. Forecast Revenue Growth
Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $2.75 per share.
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.